KUALA LUMPUR, 23/6/2021 – Pharmaniaga Berhad (Pharmaniaga) has taken up a financing facility from Standard Chartered Malaysia for the import and distribution of Sinovac COVID-19 vaccines to the public and private sectors, making the pharmaceutical group the latest recipient of the Bank’s not-for-profit USD1 billion financing commitment to battle COVID-19.
The additional supply is expected to contribute positively to the country-wide vaccine rollout by providing more people with access to vaccines as the country pushes towards its objective of achieving herd immunity by the end of 2021. The success of the National COVID-19 Immunisation Programme is seen as the key to Malaysia’s economic growth and recovery this year.
Datuk Zulkarnain Md Eusope, Group Managing Director of Pharmaniaga said the Company is supporting the Government’s fight against the pandemic by completing the contractual supplies of 12 million doses of Sinovac COVID-19 vaccines four months ahead of its delivery schedule, from November to July 2021.
Read more : Pharmaniaga selects Oracle Cloud SCM to optimize logistics ahead of COVID-19 vaccine distribution – Money Compass
Discussion about this post